Skip to content

AARD AARD Operating Lease Liabilities (Current)

Operating Lease Liabilities (Current) at other companies

Rhythm Pharmaceuticals, Inc. logo
Rhythm Pharmaceuticals, Inc.RYTM
$676K+202%
Aquestive Therapeutics, Inc. logo
Aquestive Therapeutics, Inc.AQST
$662K+22.6%
Viking Therapeutics logo
Viking TherapeuticsVKTX
$0-100%
Arvinas logo
ArvinasARVN
$1.8M-5.3%
Protagonist Therapeutics logo
Protagonist TherapeuticsPTGX
$2.34M+49.2%
Arcus Biosciences logo
Arcus BiosciencesRCUS
$13M+8.3%

Other financials

Income statement

See full
Revenue-
Operating income-$22.5M-115%
Net income-$21.6M-132%
EPS (diluted)-$0.99-39.4%

Balance sheet

See full
Cash & equivalents$62.4M+136%
Total debt$336.0K-53.7%
Total equity$87.0M-42.3%
Total assets$98.6M-37.2%

Cash flow

See full
Operating cash flow-$18.9M-65.7%
CapEx--100%
Free cash flow-$16.8M-117%

Valuation

See full
Market cap$124.35M-58.6%
Enterprise value$62.25M-77.4%

Returns & leverage

See full
Return on equity-58.8%
Debt / equity0.0×
Current ratio8.1×-17.8×

Where this comes from

Reported directly by AARD in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityCurrent.

The official record: AARD’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about AARD's operating lease liabilities (current).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AARD's operating lease liabilities (current)?
AARD (AARD) reported operating lease liabilities (current) of $336K in Q1 2026.
How has AARD's operating lease liabilities (current) changed year-over-year?
AARD's operating lease liabilities (current) decreased by 13.8% year-over-year, from $390K to $336K.
What does operating lease liabilities (current) mean?
The current portion of operating lease obligations due within one year, representing committed future lease payments under ASC 842.